drugset / Trial / NCT00731263
A Study of Tor Kinase Inhibitor in Advanced Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to assess the safety, tolerability and pharmacokinetics of AZD8055 and determine the maximum tolerated dose to take into phase II trials.
Timeline
- Start
- 2008-07
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8055 | Small molecule | — | Oral |